NexgenRx Inc. (NXG.V)
- Previous Close
0.2000 - Open
0.2200 - Bid 0.2000 x --
- Ask 0.2400 x --
- Day's Range
0.2000 - 0.2200 - 52 Week Range
0.1800 - 0.3500 - Volume
26,000 - Avg. Volume
11,856 - Market Cap (intraday)
14.106M - Beta (5Y Monthly) 0.23
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date May 6, 2024 - May 10, 2024
- Forward Dividend & Yield 0.01 (5.00%)
- Ex-Dividend Date Dec 28, 2023
- 1y Target Est
4.25
NexgenRx Inc. administers, adjudicates, and pays drug, dental, and other extended health-care claims for the beneficiaries of health benefit plans underwritten by its customers in Canada. It offers NexSys claims management; NexAdmin plan administration; and NexPSPAssist patient support programs. NexgenRx Inc. was incorporated in 2003 and is headquartered in Toronto, Canada.
www.nexgenrx.comRecent News: NXG.V
Performance Overview: NXG.V
Trailing total returns as of 4/18/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NXG.V
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NXG.V
Valuation Measures
Market Cap
14.11M
Enterprise Value
14.34M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.02
Price/Book (mrq)
2.33
Enterprise Value/Revenue
1.04
Enterprise Value/EBITDA
13.90
Financial Highlights
Profitability and Income Statement
Profit Margin
-2.40%
Return on Assets (ttm)
-0.32%
Return on Equity (ttm)
-4.01%
Revenue (ttm)
13.85M
Net Income Avi to Common (ttm)
-331.97k
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
1.88M
Total Debt/Equity (mrq)
5.99%
Levered Free Cash Flow (ttm)
1.32M